Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H2FPEF score,European Journal of Heart Failure

当前位置： X-MOL 学术 › Eur. J. Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H2FPEF score
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2024-08-27 , DOI: 10.1002/ejhf.3413
Dorien Laenens ₁ , Thomas Zegkos ₂ , Vasileios Kamperidis _{1,

2} , Raymond C C Wong ₃ , Tony Yi-Wei Li ₃ , Ching-Hui Sia ₃ , William K F Kong ₃ , Georgios Efthimiadis ₂ , Kian Keong Poh ₃ , Antonios Ziakas ₂ , Jeroen J Bax _{1,

4} , Nina Ajmone Marsan ₁

Affiliation

The aim of this study was to investigate whether the H₂FPEF score, which was developed to improve the diagnosis of heart failure (HF) with preserved ejection fraction, is associated with HF outcomes in patients with hypertrophic cardiomyopathy (HCM).

中文翻译：